Age, Biography and Wiki

Nicholas Lydon was born on 27 February, 1957, is a British biochemist. Discover Nicholas Lydon's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 67 years old?

Popular As N/A
Occupation N/A
Age 67 years old
Zodiac Sign Pisces
Born 27 February, 1957
Birthday 27 February
Birthplace N/A
Nationality

We recommend you to check the complete list of Famous People born on 27 February. He is a member of famous with the age 67 years old group.

Nicholas Lydon Height, Weight & Measurements

At 67 years old, Nicholas Lydon height not available right now. We will update Nicholas Lydon's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Nicholas Lydon Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Nicholas Lydon worth at the age of 67 years old? Nicholas Lydon’s income source is mostly from being a successful . He is from . We have estimated Nicholas Lydon's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income

Nicholas Lydon Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia Nicholas Lydon Wikipedia
Imdb

Timeline

1957

Nicholas B. Lydon FRS (born 27 February 1957) is a British scientist and entrepreneur.

1978

He earned a Bachelor of Science degree in biochemistry from the University of Leeds, England in 1978 and received his PhD in biochemistry from the University of Dundee, Scotland in 1982.

1982

In 1982, Lydon accepted a position with Schering-Plough based in France as Chargé de Récherche.

Three years later, he moved to Switzerland to work with Ciba-Geigy Pharmaceuticals, with whom he developed Gleevec.

1997

In 1997, he established Kinetex Pharmaceuticals in Boston which was acquired by Amgen in 2000, with whom he worked until 2002.

Thereafter, he established several companies that continue to develop drugs to treat various conditions.

Lydon's nomination for the Royal Society reads:

2009

In 2009, he was awarded the Lasker Clinical Award and in 2012 the Japan Prize for the development of Gleevec, also known as Imatinib, a selective BCR-ABL inhibitor for the treatment of chronic myeloid leukaemia (CML), which converted a fatal cancer into a manageable chronic condition.

Lydon was educated at Strathallan School near Perth, Scotland.